Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy.

Yoshikawa T, Rino Y, Yukawa N, Oshima T, Tsuburaya A, Masuda M.

Surg Today. 2014 Jan;44(1):11-21. doi: 10.1007/s00595-013-0529-1. Epub 2013 Mar 19. Review.

PMID:
23508452
2.

Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002).

Kinoshita T, Sasako M, Sano T, Katai H, Furukawa H, Tsuburaya A, Miyashiro I, Kaji M, Ninomiya M.

Gastric Cancer. 2009;12(1):37-42. doi: 10.1007/s10120-008-0496-1. Epub 2009 Apr 24.

PMID:
19390930
3.

Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.

Fujitani K.

Dig Surg. 2013;30(2):119-29. doi: 10.1159/000350877. Epub 2013 Jul 18. Review.

4.

[Neoadjuvant Chemotherapy for Gastric Cancer].

Yoshikawa T, Sato T, Yamada T, Aoyama T, Ogata T, Cho H.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1157-1160. Japanese.

PMID:
27760932
5.

Adjuvant and neoadjuvant therapy for gastric cancer.

Kelsen DP.

Semin Oncol. 1996 Jun;23(3):379-89. Review.

PMID:
8658222
6.

Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan.

Kodera Y.

Surg Today. 2017 Aug;47(8):899-907. doi: 10.1007/s00595-017-1473-2. Epub 2017 Feb 28. Review.

PMID:
28247105
7.

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators.

Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7.

PMID:
22226517
8.

Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer.

Takahashi S, Kinoshita T, Konishi M, Nakagouri T, Inoue K, Ono M, Sugitou M, Ohtsu A, Boku N, Yoshida S.

Gastric Cancer. 2001;4(4):192-7.

PMID:
11846062
9.

Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.

Kunisaki C, Makino H, Kimura J, Takagawa R, Kanazawa A, Ota M, Kosaka T, Ono HA, Akiyama H, Endo I.

Oncology. 2015;88(5):281-8. doi: 10.1159/000369497. Epub 2015 Jan 14.

PMID:
25591954
10.

Adjuvant and neoadjuvant therapy for gastric cancer.

Oh DY, Bang YJ.

Curr Treat Options Oncol. 2013 Sep;14(3):311-20. doi: 10.1007/s11864-013-0238-4.

PMID:
23686725
11.
12.

What make differences in the outcome of adjuvant treatments for resected gastric cancer?

Nakajima T, Fujii M.

World J Gastroenterol. 2014 Sep 7;20(33):11567-73. doi: 10.3748/wjg.v20.i33.11567. Review.

13.

Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin.

Maeda O, Iwase H, Mamiya N, Nakamura M, Mizuno T, Nishio Y, Ando T, Ina K, Kusugami K.

Intern Med. 2000 Mar;39(3):239-44.

14.
15.

Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.

Choi AH, Kim J, Chao J.

World J Gastroenterol. 2015 Jun 28;21(24):7343-8. doi: 10.3748/wjg.v21.i24.7343. Review.

16.

[A case of scirrhous gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy].

Kameyama S, Murayama R, Miyazato K, Kurashita K, Ishimine T, Nagamine Y, Kohakura F, Shinzato S, Tomimori K, Kugai Y, Uchima H.

Gan To Kagaku Ryoho. 2006 Apr;33(4):509-11. Japanese.

PMID:
16612163
17.

[A Patient Who Underwent Surgery after CR to Chemotherapy for Scirrhous Gastric Cancer Suspected because of Lymphangitis Carcinomatosa].

Nishiki K, Tanaka Y, Sogabe S, Iwama M, Makino T, Shiraishi O, Yasuda A, Shinkai M, Imano M, Imamoto H, Furukawa H, Yasuda T.

Gan To Kagaku Ryoho. 2015 Jun;42(6):739-42. Japanese.

PMID:
26199248
18.

[Neoadjuvant chemotherapy for gastric cancer--evidence from the world and future strategy in Japan].

Yoshikawa T, Aoyama T, Hayashi T, Kuwabara H, Mikayama Y, Ogata T, Cho H, Tsuburaya A.

Gan To Kagaku Ryoho. 2012 Jun;39(6):866-70. Japanese.

PMID:
22705680
19.

Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.

Honma Y, Yamada Y, Terazawa T, Takashima A, Iwasa S, Kato K, Hamaguchi T, Shimada Y, Ohashi M, Morita S, Fukagawa T, Machida N, Katai H.

Surg Today. 2016 Sep;46(9):1076-82. doi: 10.1007/s00595-015-1276-2. Epub 2015 Nov 13.

PMID:
26563224
20.

[Timing of surgery after neoadjuvant chemotherapy for advanced gastric cancer].

Hu X.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jun;16(6):509-12. Chinese.

PMID:
23801199

Supplemental Content

Support Center